
Continued research shows that earlier treatment significantly enhances tissue preservation in patients with geographic atrophy, emphasizing the importance of timely intervention.

Continued research shows that earlier treatment significantly enhances tissue preservation in patients with geographic atrophy, emphasizing the importance of timely intervention.

In the Phase 2 TEASE 2 trial, gildeuretinol was well tolerated and showed promising trends in slowing ellipsoid zone loss and preserving low-luminance visual acuity in patients with Stargardt disease.

A study shows enhanced safety and efficacy in epi-on cross-linking for keratoconus, utilizing oxygen-rich boost goggles during treatment.

A new study reveals enhanced safety and efficacy in epi-on cross-linking for keratoconus, utilizing oxygen-rich boost goggles during treatment.

The second day of the annual scientific meeting of the American Academy of Ophthalmology highlighted advancements in AI, surgery technology, and money-saving solutions.

Data suggests the candidate can reduce the number of injections and treatment burden for patients

Dr. Singh reported that when technicians understand why they are performing a diagnostic test, they perform better and think critically in patient care situations.

The first day of the American Academy of Ophthalmology meeting in Orlando, Florida featured presentations centered on eye injuries and data insights.

Dr Khanani shared his first-time results talk during an AAO specialty day

The 18-month extension of the GATHER2 trial indicated continued benefit for patients receiving avacincaptad pegol, with efficacy gains increasing over time.

At the 2025 Academy of American Ophthalmology meeting, Prof Stalmans described safety and efficacy benefits of disposable non-contact vitrectomy lenses

Durga Borkar, MD, MMCi, explores real-world treatment patterns and safety of avacincaptad pegol for geographic atrophy, revealing critical insights for patient care.

Dr Borkar, a vitreoretinal surgeon at Duke University, spoke to the Eye Care Network about her American Academy of Ophthalmology (AAO) presentation

AAO attendees can preview the new technician training platform on Sunday, October 19.

Jean-Francois Korobelnik, MD, shares highlights from the PULSAR extension study showcasing aflibercept 8 mg and its ability to promote fluid resolution

Data suggests the candidate can reduce the number of injections and treatment burden for patients

This year, 18 presenters will deliver named lectures during the American Academy of Ophthalmology meeting.

An easy reference guide for this year's award lectures and subspecialty day keynotes.

The video-driven platform will improve workflow, education and engagement, said Inder Paul Singh, MD.

The video-driven platform will improve workflow, education and engagement, said Inder Paul Singh, MD

Attendees of the AAO 2025 annual meeting will have a chance to preview the virtual technician training platform on October 19, at 10:30 am in the Academy Theater, Hall WB1, Booth 2761.

Singh highlights how understanding the “why” behind diagnostics and procedures boosts technician confidence, fosters pride, and strengthens their role in patient care.

The video-driven platform equips ophthalmic practices with tools to standardize education, improve workflow, and foster technician engagement.

The agenda includes subspecialty days, evening events and partner programmes from practice management organisations

Join the American Academy of Ophthalmology's annual meeting for cutting-edge insights, networking, and engaging events from October 17-20 in Orlando.


Discover key insights from leading ophthalmology experts at the AAO meeting, featuring presentations, posters, and innovative discussions from October 17-20.


Five years after the COVID-19 pandemic shutdown reshaped how the world gathers, here's how some of ophthalmology’s leading associations are still applying lessons forged in crisis

The annual meeting, held in Chicago, Illinois, featured new data and best practices for patient-centered care.